Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Cell Biol Int ; 45(1): 61-73, 2021 Jan.
Article in English | MEDLINE | ID: mdl-32936498

ABSTRACT

Osteosarcoma (OS) is a rare malignancy of bone associated with poor clinical outcomes. The antitumor effects of GANT61 on OS is unclear. To investigate antitumor effects and mechanism of GANT61 in OS cells and xenograft model. Effects of GANT61 on cell viability, clone formation, cell cycle, apoptosis, migration, and invasion ability of OS cells were assessed. Reactive oxygen species (ROS) levels measured by dichlorofluorescein fluorescence were used to evaluate oxidative stress. The Xenograft model was constructed to investigate the antitumor effects of GANT61 in vivo. The microRNA (miRNA)-1286 was downregulated, while RAB31 upregulated in OS tissues and cells. GANT61 inhibited viability, migration, and invasion ability of OS cells (SaOS-2 and U2OS), and induced apoptosis and the ROS production, along with miRNA-1286 upregulation and RAB13 downregulation. After knockdown of miRNA-1286, GANT6-induced cell inhibition was attenuated, along with RAB31 upregulation. Inversely, miRNA-1286 overexpression downregulated RAB31. Dual-luciferase reporter assay verified that miR-1286 negatively targeted RAB13. Moreover, the knockdown of RAB31 stimulated apoptosis and ROS production while inhibited viability, migration, and invasion of GANT61-treated cells. In vivo experiments further confirmed that GANT61 inhibited tumor growth and RAB13 expression, but enhanced miRNA-1286. The study demonstrated that GANT61 inhibited cell aggressive phenotype and tumor growth by inducing oxidative stress through the miRNA-1286/RAB31 axis. Our findings provided a potential antitumor agent for the OS clinical treatment.


Subject(s)
Antineoplastic Agents/pharmacology , MicroRNAs/metabolism , Osteosarcoma/genetics , Oxidative Stress/drug effects , Pyridines/pharmacology , Pyrimidines/pharmacology , rab GTP-Binding Proteins/metabolism , Animals , Base Sequence , Cell Line, Tumor , Cell Movement/drug effects , Cell Proliferation/drug effects , Female , Gene Expression Regulation, Neoplastic/drug effects , Humans , Mice, Inbred BALB C , Mice, Nude , MicroRNAs/genetics , Neoplasm Invasiveness , Osteosarcoma/pathology , Oxidative Stress/genetics , Xenograft Model Antitumor Assays
2.
Cell Biol Int ; 41(3): 287-295, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28032380

ABSTRACT

MiR-195-5p has been shown to play an essential role in human cancer progression. Nevertheless, the biological role of miR-195-5p in osteosarcoma development remains unclear. In this study, real-time PCR was performed to examine the miR-195-5p expression in human osteosarcoma cell lines. CCK-8 assay and Transwell assay were carried out to measure the effect of miR-195-5p on cell proliferation and invasion. Luciferase reporter assay was used to identify the targets of miR-195-5p. The results showed that miR-195-5p was significantly downregulated in osteosarcoma cells. Forced expression of miR-195-5p significantly inhibited cell proliferation, suppressed cell migration and invasion, compared with wild-type and control-transfected osteosarcoma cells. Luciferase reporter assay revealed that miR-195-5p binds to the 3'-untranslated region (UTR) of Naked cuticle homolog 1 (NKD1), indicating that NKD1 was a novel target of miR-195-5p. NKD1 mRNA and protein levels were reduced after overexpression of miR-195-5p. Moreover, silencing of NKD1 significantly inhibited the proliferation and invasion of osteosarcoma cells. Accordingly, our results support a tumor suppressor role of miR-195-5p in osteosarcoma through inhibiting NKD1, and it may be a promising therapeutic target for osteosarcoma.


Subject(s)
Bone Neoplasms/metabolism , Carrier Proteins/metabolism , Cell Proliferation/physiology , MicroRNAs/metabolism , Osteosarcoma/metabolism , Adaptor Proteins, Signal Transducing , Animals , Bone Neoplasms/genetics , Bone Neoplasms/pathology , Calcium-Binding Proteins , Carrier Proteins/antagonists & inhibitors , Carrier Proteins/genetics , Cell Line, Tumor , Cell Movement/physiology , Gene Knockdown Techniques , Humans , Mice , MicroRNAs/genetics , Neoplasm Invasiveness/genetics , Neoplasm Invasiveness/pathology , Osteosarcoma/genetics , Osteosarcoma/pathology
3.
Acta Trop ; 145: 1-7, 2015 May.
Article in English | MEDLINE | ID: mdl-25661801

ABSTRACT

The Xinjiang Uyghur Autonomous Region in northwest China is one of the world's most important foci for cystic echinococcosis. Domestic dogs are the main source for human infection, and previous studies in Xinjiang have found a canine Echinococcus spp. coproELISA prevalence of between 36% and 41%. In 2010 the Chinese National Echinococcosis Control Programme was implemented in Xinjiang, and includes regular dosing of domestic dogs with praziquantel. Six communities in Hobukesar County, northwest Xinjiang were assessed in relation to the impact of this control programme through dog necropsies, dog Echinococcus spp. coproantigen surveys based on Lot Quality Assurance Sampling (LQAS) and dog owner questionnaires. We found that 42.1% of necropsied dogs were infected with Echinococcus granulosus, and coproELISA prevalences were between 15% and 70% in the communities. Although approximately half of all dog owners reported dosing their dogs within the 12 months prior to sampling, coproELISA prevalence remained high. Regular praziquantel dosing of owned dogs in remote and semi-nomadic communities such as those in Hobukesar County is logistically very difficult and additional measures should be considered to reduce canine echinococcosis.


Subject(s)
Dog Diseases/drug therapy , Dog Diseases/epidemiology , Echinococcosis/epidemiology , Echinococcosis/veterinary , Echinococcus granulosus/drug effects , Praziquantel/therapeutic use , Zoonoses/prevention & control , Animals , China/epidemiology , Dogs , Echinococcosis/drug therapy , Humans , Lot Quality Assurance Sampling , Prevalence , Surveys and Questionnaires
4.
Zhonghua Liu Xing Bing Xue Za Zhi ; 31(3): 297-9, 2010 Mar.
Article in Chinese | MEDLINE | ID: mdl-20510057

ABSTRACT

OBJECTIVE: To study the risk factors of human cystic echinococcosis (CE) in Hobukesar Mongolian Autonomous County of Xinjiang (HMACX) and to discuss the related strategies for prevention and control. METHODS: A randomized sampling method was used to screen local residents for human CE in HMACX. CE related risk factors including ethnicity, age, sex, occupation and personal status on hygiene etc. were analyzed under multi-factor logistic regression. RESULTS: The prevalence rates of CE and alveolar echinococcosis (AE) were 3.7% (23/627) and 0.16% (1/627) respectively, with the seropositive rate as 12.4% (76/613). The main risk factors that significantly associated with CE were age (OR = 7.6, 95%CI: 2.481 - 23.579) and slaughtering livestock in the households (OR = 3.2, 95%CI: 1.297 - 7.809). Herdsmen had the highest prevalence of CE in all of the occupations in this study. CONCLUSION: HMACX had been a highly endemic area for human CE, with age and family slaughtering-livestock-behavior appeared to be the main possible risk factors.


Subject(s)
Echinococcosis/epidemiology , Adolescent , Adult , Aged , Child , China/epidemiology , Female , Humans , Logistic Models , Male , Middle Aged , Prevalence , Risk Factors , Surveys and Questionnaires , Young Adult
5.
J Tradit Chin Med ; 30(4): 254-8, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21287781

ABSTRACT

OBJECTIVE: To probe into the mechanism of the Chinese herbs with functions of reinforcing kidney and supplementing qi for preventing knee osteoarthritis of the rabbit. METHODS: Totally 72 healthy Japan long-ear white rabbits, aged 4 months, were randomly divided into 6 groups, blank group (A), model group (B), high dose Chinese herb group (C), middle dose Chinese herb group (D), small dose Chinese herb group (E), aminoglucose hydrochloride capsule control group (F), 12 rabbits in each group. All the rabbits in the groups, except the group A, were fixed with plaster cast for six weeks to establish rabbit knee osteoarthritis. At the same time of modeling, the different doses of Juanbi Capsules and aminoglucose hydrochloride capsule were administrated intragastrically in the group C, D, E, F, respectively, for 4 weeks, for preventive treatment. In the group B, the rabbit was administrated intragastrically with equal volume of normal saline to the medication groups, twice each day, in the morning and the evening, and in the group A, nothing was administrated. After modeling for 6 weeks, the joint fluid was taken and TNF-alpha, IL-1 and IL-6 contents were detected with ELISA method, and the articular cartilage was taken for macroscopic and microscopic examinations. RESULTS: In all the preventive treatment groups, the articular cartilage color changed to varying degrees with formation of osteophyte and bone cyst, superficial erosion on the chondral articular surface, and the cartilage defect reached to the mid layer in a part of specimens with cartilage exfoliation, but which in the extent were significantly lower than those in the model group. There were significant differences between the group A and B in TNF-alpha, IL-1 and IL-6 contents in the joint fluid (P < 0.05), indicating that the modeling is successful; and there were significant differences as group B compared with the group C,D, E, F, showing that TNF-alpha , IL-1 and IL-6 contents are decreased in all the medication groups; and significant differences between group C, D, E suggests that the increase of Chinese herb doses strengthened the effect of reducing TNF-alpha, IL-1 and IL-6 contents in joint fluid. CONCLUSION: The Juanbi Capsule prevents osteoarthritis possibly through decreasing serum TNF-alpha, IL-1 and IL-6 contents.


Subject(s)
Drugs, Chinese Herbal/administration & dosage , Interleukin-1/immunology , Interleukin-6/immunology , Osteoarthritis, Knee/prevention & control , Synovial Fluid/drug effects , Tumor Necrosis Factor-alpha/immunology , Animals , Capsules , Disease Models, Animal , Humans , Knee Joint/drug effects , Knee Joint/immunology , Male , Osteoarthritis, Knee/drug therapy , Osteoarthritis, Knee/immunology , Rabbits , Random Allocation , Synovial Fluid/immunology
6.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 26(2): 123-4, 127, 2006 Feb.
Article in Chinese | MEDLINE | ID: mdl-16548351

ABSTRACT

OBJECTIVE: To study the clinical effect of Jieguxujin granule (JGXJG) on fracture and its effect on serum content of calcitonin gene related peptide (CGRP). METHODS: Four hundred patients with fracture were randomly divided into 2 groups, the JGXJG treated group and the control group treated with Sanqi tablet (SQT). Serum CGRP was tested with radioimmunoassay once every 3 days for 5 times, and X-ray examination was taken once each week for 10 weeks. RESULTS: The healing time of fracture and osteotylus forming time in the JGXJG group was shorter than those in the SQT group significantly (P < 0.005). Serum CGRP content in JGXJG group was higher remarkably (P < 0.05, P < 0.01). CONCLUSION: JGXJG showed evident effect in promoting union of fracture healing, it could also increase the CGRP content in serum.


Subject(s)
Calcitonin Gene-Related Peptide/blood , Femoral Fractures/drug therapy , Fracture Healing/drug effects , Fractures, Bone/drug therapy , Phytotherapy , Adolescent , Adult , Aged , Aged, 80 and over , Child , Drugs, Chinese Herbal/therapeutic use , Female , Humans , Humeral Fractures/drug therapy , Male , Middle Aged , Tibial Fractures/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...